Therefore, our results support the hypothesis that blocking LTα may serve as a viable target for JIA treatment, echoing previous suggestions for rheumatoid arthritis management (Buch et al., 2004; Calmon-Hamaty et al., 2011a; Calmon-Hamaty et al., 2011b). The gene discussed is LTA; the disease is juvenile idiopathic arthritis.